1994
DOI: 10.1002/art.1780370621
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of stiff‐man syndrome with intravenous immune globulin

Abstract: IVIG may be useful for the treatment of SMS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
29
0

Year Published

1999
1999
2011
2011

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 53 publications
(30 citation statements)
references
References 14 publications
1
29
0
Order By: Relevance
“…Immunotherapy has been reported to be a good therapeutic approach in these patients, but results are controversial. The use of intravenous gammaglobulins in a subgroup of patients with stiff-person syndrome seems to be of therapeutic value [44], as in other immunological diseases affecting the nervous system.…”
Section: Clinicalmentioning
confidence: 99%
“…Immunotherapy has been reported to be a good therapeutic approach in these patients, but results are controversial. The use of intravenous gammaglobulins in a subgroup of patients with stiff-person syndrome seems to be of therapeutic value [44], as in other immunological diseases affecting the nervous system.…”
Section: Clinicalmentioning
confidence: 99%
“…Patients not responsive to or unable to tolerate corticosteroids can be treated with intravenous immune globulin (IVIG) given over 3-5 days [9,10]. The duration of the beneficial effects of IVIG varied from 6 weeks to 1 year.…”
mentioning
confidence: 99%
“…Several case reports have also shown a beneficial effect in the treatment of SMS [20,21,24]. Our patient received IVIG treatment once per week for 3 months in addition to plasmapheresis and prednisone.…”
mentioning
confidence: 78%
“…Response to plasmapheresis has been inconsistent with both a beneficial response and no effect being reported [15][16][17][18][19]. Improvement following steroid treatment or intravenous immune globulin administration has also been reported in several cases [20][21][22][23][24]. We report a patient with both SMS and type 1 diabetes who did not fully respond to the conventional treatment with diazepam and baclofen.…”
mentioning
confidence: 90%